Christian Eriksen and the COVID Vaccine UK 2026: What the Evidence Actually Shows About Myocarditis Risk

Christian Eriksen had not received a COVID-19 vaccine when he suffered cardiac arrest on 12 June 2021 — Denmark had not yet vaccinated his age group. The genuine UK myocarditis data for mRNA vaccines is real but small: 10-20 events per 100,000 in young males after a second dose, mostly mild, and around 11 times smaller than the risk from COVID infection itself.

You may have seen the clip. Christian Eriksen running near the left touchline at Parken Stadium in Copenhagen, then falling face-first onto the turf. The clip is replayed on social media with a caption suggesting the COVID vaccine caused it. Perhaps a relative has forwarded the post. Perhaps you are weighing an autumn booster, or wondering whether to ask your GP about your teenage son’s heart. The question is reasonable. When something happens to the heart, people deserve straight answers.

This article is for you. It walks through the documented timeline of what happened on 12 June 2021, what Eriksen’s clinical team have publicly said, what the most likely medical explanation is, and what the broader UK evidence shows about mRNA vaccines and myocarditis. It covers how the JCVI has updated UK vaccination policy by 2026 and what to do if you or your child experience chest pain after a COVID vaccine dose. It is written in a calm, GP-clinic voice — neither dismissive of vaccine concerns nor entertaining of claims that the documented timeline disproves.

If you came here looking for a simple yes or no, the headline version is: Eriksen was not vaccinated on the day, and the documented myocarditis data is real but small. Read on for the detail behind both statements.

What actually happened to Christian Eriksen on 12 June 2021

On 12 June 2021, Denmark played Finland in a Euro 2020 group-stage match at Parken Stadium in Copenhagen. In the 42nd minute, with the score at 0-0, Christian Eriksen was jogging near the left touchline after receiving a throw-in. He had no contact with any other player. He stumbled, took two unsteady steps, and collapsed face-down onto the pitch.

Team captain Simon Kjaer was the first player to reach him, turning Eriksen onto his side within seconds and clearing his airway. The Danish medical team, led by team doctor Morten Boesen, arrived almost immediately. CPR was started on the pitch. An automated external defibrillator was attached and delivered a single shock. Eriksen regained consciousness before being carried off on a stretcher, and television cameras captured him blinking and breathing with his hand on his forehead.

At the post-match press conference, Boesen told reporters that Eriksen “was gone” before being resuscitated. He was taken to Rigshospitalet, Copenhagen’s principal university hospital. An implantable cardioverter defibrillator, or ICD, was fitted on 18 June 2021. Eriksen walked out of hospital the same day.

The incident was broadcast live across Europe on BBC, Sky Sports and other networks. The on-pitch response — immediate recognition, early CPR, rapid defibrillation — is now used as a teaching case by Resuscitation Council UK and in FIFA’s own stadium medical guidance.

A 29-year-old elite athlete suffered an unexplained cardiac arrest during a live televised match, was resuscitated by prompt CPR and a defibrillator, and recovered well enough to return to Premier League football within nine months and to score for Denmark at Euro 2024, three years after the event.

The vaccine timeline — Eriksen was not vaccinated on 12 June 2021

This is the central evidential point, and it is straightforward. On 12 June 2021, Christian Eriksen had not received any dose of a COVID-19 vaccine.

Denmark’s COVID-19 vaccination programme had begun in late December 2020, following the same phased approach used across Europe and the UK. By June 2021, the rollout had reached care home residents, frontline healthcare workers, adults over 50, and people in high-risk medical categories. The programme was beginning to extend to adults in their thirties and forties from late June onwards. Healthy adults under 30 were not generally called for vaccination until July and August 2021.

Eriksen was 29 years old. He had no chronic health conditions. He had no professional priority category that would have moved him ahead in the queue. He had not received a vaccine because the rollout had not reached him.

This has been confirmed publicly by his Inter Milan club doctor Volker Klusen in interviews with Italian media, by the Danish Football Union, and by Eriksen himself in subsequent press conferences. The same was true for the majority of his Danish national team and Inter Milan colleagues — most were unvaccinated at the time of Euro 2020 because their age groups had not yet been called.

Reuters Fact Check, AFP Fact Check, AP Fact Check and Full Fact, the UK fact-checking charity, have all independently verified the timeline and published debunkings of the social-media claim. The claim that the COVID vaccine caused Eriksen’s collapse rests on something that had not happened to him. This is not a debate about whether mRNA vaccines can rarely cause myocarditis — they can. It is a simple matter of dates.

What the real cause was likely to be

The Danish medical team have not publicly named a single confirmed diagnosis for what caused Eriksen’s cardiac arrest. At the initial press conference, Morten Boesen said plainly: “We do not have an explanation as to why it happened.” Investigations at Rigshospitalet and subsequent follow-up by Eriksen’s cardiology team have not changed that public position.

What can be said is that the clinical pattern — sudden cardiac arrest with ventricular fibrillation in a previously healthy young athlete, with no obvious structural abnormality on routine echocardiography — is a well-recognised presentation in sports cardiology. It is not new. It is not rare. It is the kind of event that the UK charity Cardiac Risk in the Young, founded in 1995, has worked to prevent for decades.

The most likely categories of explanation, according to the European Society of Cardiology and standard cardiology references, include the following:

• An inherited channelopathy — Long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia — which affects the heart’s electrical signalling without necessarily showing on a standard echocardiogram.
• Hypertrophic cardiomyopathy, where the wall of the heart thickens, sometimes subtly enough to evade routine screening.
• Arrhythmogenic right ventricular cardiomyopathy.
• A congenital coronary artery anomaly.
• Idiopathic ventricular fibrillation, which is the term used when no structural or electrical cause is identified despite thorough investigation.

Eriksen’s pre-incident cardiac screening at Tottenham Hotspur, where he played from 2013 to 2020, was normal. His screening at Inter Milan and with the Danish national team was also within normal limits. This is consistent with what happens in a meaningful minority of cases: routine pre-participation screening — typically a 12-lead ECG and an echocardiogram — misses an estimated 5 to 15 percent of underlying conditions. Many channelopathies and microscopic cardiomyopathies produce no symptoms and no detectable abnormality until the first cardiac event.

Eriksen’s ICD now provides a safety net. If a similar arrhythmia were to recur, the device delivers an automatic shock within seconds. He has played hundreds of competitive minutes since — for Brentford, for Manchester United, and for Denmark — with no device-triggered incident, which is exactly how the technology is designed to work.

What the UK evidence actually shows about mRNA vaccines and myocarditis

This is the separate, legitimate part of the story, and it deserves a clear answer.

The mRNA COVID vaccines — Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) — are associated with a rare raised risk of myocarditis and pericarditis. This is not disputed. The UK Medicines and Healthcare products Regulatory Agency (MHRA) identified the signal through its Yellow Card adverse-reaction reporting scheme, and it has been confirmed in multiple large epidemiological studies.

The risk is most concentrated in young males after the second dose, and particularly after the Moderna vaccine. UK MHRA Yellow Card data and large self-controlled case series studies published in the BMJ and Nature Medicine give approximate absolute rates of 10 to 20 myocarditis events per 100,000 in 12 to 29 year old males after the second mRNA dose. Some sub-analyses have estimated higher rates in the youngest subgroup — around 66.7 per million in 12 to 17 year old males after the second dose in certain series. The risk is lower in females, lower in older adults, and lower after first and booster doses.

The NHS England self-controlled case series, which covered approximately 50 million eligible vaccine recipients between February 2021 and February 2022, estimated around 10 extra myocarditis events per million in the 28 days after a second mRNA-1273 dose. That is a real signal. It informed JCVI policy.

The comparison that matters, however, is with COVID-19 infection itself. The American Heart Association journal Circulation published data in 2022 showing that the risk of myocarditis after SARS-CoV-2 infection is approximately 11 times higher than the risk after vaccination. The BMJ and Nature Medicine have published similar findings. In other words, for a young man deciding between vaccination and the near-certainty of eventual COVID infection, the infection itself carries a substantially higher myocarditis risk.

The clinical course of post-vaccine myocarditis is typically mild. Most cases present with chest pain, breathlessness or palpitations within one to seven days of the dose and recover fully on rest and standard anti-inflammatories within weeks. Long-term cardiac MRI follow-up studies have been broadly reassuring.

How the UK JCVI vaccine programme has evolved by 2026

The Joint Committee on Vaccination and Immunisation has reviewed the balance of clinical benefit and rare myocarditis risk for low-risk groups multiple times between 2022 and 2026. The result is a UK COVID-19 vaccination programme in 2026 that is substantially narrower than the one that operated in 2021 and 2022.

As of June 2026, routine COVID-19 boosters through the NHS are offered to adults aged 65 and over, residents of care homes for older adults, and clinically vulnerable people of any age. The clinically vulnerable category includes people who are immunosuppressed, those with severe respiratory disease, and those with chronic heart, kidney or liver conditions.

Healthy adults under 65 are no longer routinely called for boosters. Routine vaccination of healthy children and adolescents has been discontinued. Vaccines remain available privately for travel and personal protection.

The JCVI’s published reasoning, available in minutes on gov.uk, reflects the evolving evidence. At high levels of population immunity — built through a combination of vaccination and prior infection across the UK population — the clinical benefit of routine booster vaccination in low-risk groups is smaller than it was in 2021. The small but real myocarditis risk in young males, documented in the MHRA data and the BMJ self-controlled case series, weighs against a routine offer for groups where the absolute clinical benefit is low.

This is not a retraction of the original programme. The UK mRNA vaccine rollout of 2021 to 2022 is widely accepted, on the basis of published mortality and hospitalisation data, as having prevented a very large number of deaths. It is a normal evolution of policy as the balance of risk and benefit changes with population-level immunity. The autumn 2026 booster campaign began in late September and uses updated vaccines matched to circulating variants.

What to do if you or your child have chest pain after a COVID vaccine

If you or your child has recently received a COVID-19 vaccine, it is worth knowing what post-vaccine myocarditis looks like so you can act promptly if needed. The condition is rare, but recognising it early leads to better outcomes.

Symptoms typically appear one to seven days after the dose, most commonly within the first three days. Watch for chest pain or tightness, particularly when lying flat or taking a deep breath. Shortness of breath, palpitations or a noticeably racing heart, light-headedness, fainting, or fatigue that seems out of proportion to recent activity are also signals.

If these symptoms develop after a recent COVID vaccine, call 111 or attend your nearest A&E department. Tell the clinical team clearly that the symptoms started after a recent COVID-19 vaccine dose and state the date of vaccination. This helps them prioritise correctly. Most cases require an ECG, a troponin blood test, and sometimes a cardiac MRI to confirm the diagnosis.

Treatment is usually supportive — rest, oral anti-inflammatories such as ibuprofen or naproxen, and follow-up with a cardiologist. Most patients, particularly younger patients, make a full recovery within weeks. Current European Society of Cardiology guidance recommends avoiding competitive sport and strenuous exercise for three to six months after a confirmed diagnosis.

You should also report the suspected adverse reaction through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. Reports can be filed by patients, parents, or healthcare professionals. This is the system through which the UK monitors vaccine safety in real time. The Yellow Card data you contribute is exactly what produced the self-controlled case series published in the BMJ in 2022, which in turn informed JCVI policy. Reporting a suspected side effect is not an act of blame. It is the safety monitoring system working as designed.

Frequently Asked Questions

Was Christian Eriksen vaccinated against COVID when he collapsed at Euro 2020?

No. On 12 June 2021, Eriksen had not received any COVID-19 vaccine. Denmark’s rollout at that point had reached older adults and high-risk groups but had not yet called healthy adults under 30. His Inter Milan club doctor Volker Klusen, the Danish FA, and Eriksen himself have confirmed this. UK fact-checkers including Full Fact and Reuters Fact Check have independently debunked the social-media claim multiple times. The claim is contradicted by the documented vaccine rollout timeline.

What actually caused Christian Eriksen’s cardiac arrest?

The Danish medical team have not publicly named a specific diagnosis. The clinical pattern is consistent with one of several recognised electrical or structural heart conditions seen in young athletes — Long QT or Brugada channelopathies, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, or idiopathic ventricular fibrillation. Routine cardiac screening misses an estimated 5 to 15 percent of these conditions. The Cardiac Risk in the Young UK charity has campaigned for better screening since 1995. Eriksen now has an ICD as a backup.

Do mRNA COVID vaccines cause myocarditis in young men?

They are associated with a rare raised risk, particularly in young males after the second dose. UK MHRA Yellow Card data and large self-controlled case series published in the BMJ show approximately 10 to 20 myocarditis events per 100,000 in 12 to 29 year old males after a second mRNA dose, mostly mild and self-limiting. The risk of myocarditis after COVID-19 infection itself is roughly 11 times higher than after vaccination, according to the American Heart Association journal Circulation in 2022.

Is the UK still vaccinating children against COVID in 2026?

No, not routinely. The JCVI has progressively narrowed the UK COVID programme since 2022. In 2026, routine NHS boosters are offered only to adults aged 65 and over, care home residents, and clinically vulnerable people of any age, including those who are immunosuppressed or have severe heart, lung, kidney or liver conditions. Healthy children, adolescents and under-65 adults are not routinely called. Vaccines remain available privately for travel or personal protection.

What are the symptoms of post-vaccine myocarditis and when should I worry?

Watch for chest pain or tightness, particularly when lying flat or breathing deeply, shortness of breath, palpitations, light-headedness, fainting, or fatigue out of proportion to recent activity. Symptoms typically appear one to seven days after the dose, most often within three days. If you or your child develop these symptoms after a recent COVID vaccine, call 111 or go to A&E and mention the vaccine timing. Most cases recover fully on rest and anti-inflammatories within weeks.

Should I report a suspected vaccine side effect?

Yes. The UK MHRA Yellow Card scheme at yellowcard.mhra.gov.uk is the official route for reporting suspected adverse reactions to any vaccine or medicine. Reports can be filed by patients, parents or healthcare professionals. Yellow Card data is the foundation of UK post-marketing safety monitoring, including the self-controlled case series that produced the 2022 BMJ myocarditis estimates. The process takes about ten minutes online. It is how the system stays accountable.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.